In today's
VETgirl online veterinary continuing education
podcast, Dr.
Ashlie Saffire, DAVBP (feline practice), discusses Felcyin-CA1 (sirolimus delayed-release tablets), an FDA conditionally approved treatment option to slow the progression of hypertrophic cardiomyopathy (HCM) in cats manufactured by
PRN Pharmacal. HCM is known as the silent killer in cats! Tune in to find out if Felycin-CA1 is the right choice for your HCM patient!
Sponsored By:
PRN Pharmacal